4.8 Article

Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity

Journal

SCIENCE
Volume 305, Issue 5681, Pages 242-245

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1098991

Keywords

-

Funding

  1. NIA NIH HHS [AG-16339, AG-15709] Funding Source: Medline
  2. NINR NIH HHS [NRSA 44748] Funding Source: Medline

Ask authors/readers for more resources

Numerous degenerative disorders are associated with elevated levels of pro-oxidants and declines in mitochondrial aconitase activity. Deficiency in the mitochondrial iron-binding protein frataxin results in diminished activity of various mitochondrial iron-sulfur proteins including aconitase. We found that aconitase can undergo reversible citrate-dependent modulation in activity in response to pro-oxidants. Frataxin interacted with aconitase in a citrate-dependent fashion, reduced the level of oxidant-induced inactivation, and converted inactive [3Fe-4S](1+) enzyme to the active [4Fe-4S](2+) form of the protein. Thus, frataxin is an iron chaperone protein that protects the aconitase [4Fe-4S](2+) cluster from disassembly and promotes enzyme reactivation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available